Ionis alexander disease
WebTo evaluate safety and efficacy of ION373 in Alexander Disease. Research type. Research Study. Full title. A Phase 1-3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, ... Ionis Pharmaceuticals, Inc. Eudract number. 2024-000976-40. Duration of Study in the UK. 4 years, 6 months, 0 days. WebIONIS-FXI RX (BAY2306001) is an antisense oligonucleotide that inhibits the synthesis of coagulation factor XI (FXI) and has been investigated in healthy volunteers and patients with end-stage renal disease (ESRD). FXI-LICA (BAY2976217) shares the same RNA sequence as IONIS-FXI RX …
Ionis alexander disease
Did you know?
Web30 sep. 2024 · Alexander disease (AxD) is a rare neurological condition characterized as a leukodystrophy, or a disease affecting the myelin sheath (the fatty insulation that protects a nerve fiber and supports signal conduction). Two major types of AxD …
Web20 apr. 2024 · Alexander disease is a rare neurological condition characterized as a leukodystrophy, or a disease affecting the myelin sheath (the fatty insulation that … Web4 jan. 2024 · BIIB115/ION306 represents another example of our productive collaboration with Biogen to discover and develop medicines that have potential to significantly benefit patients suffering from neurological diseases,” said C. Frank Bennett, Ph.D., Executive Vice President, Chief Scientific Officer and Franchise Leader for Neurological Programs at Ionis.
Web17 okt. 2024 · ALS is a progressive neurodegenerative disease that is uniformly fatal with an average survival of three to five years. The most common cause of death is respiratory failure. SOD1-ALS is a rare, genetic form of ALS that accounts for approximately two percent of the estimated 168,000 people who have the disease globally. WebIn each episode of Ionis Innovations podcast, our host Dave Ecker and his guests will explore the fascinating field of drug discovery. Skip ... she leads research on investigational medicines to treat Alexander disease and Pelizaeus-Merzbacher disease, two rare neurodevelopmental disorders affecting young children. Elaine Pirie, Ph.D ...
WebIONIS-MAPT Rx is being developed to treat people with Alzheimer’s disease (AD) and potentially other neurodegenerative disorders characterized by the deposition of abnormal tau protein in the …
Web20 jun. 2024 · Background: Diacylglycerol-O-acyltransferase 2 (DGAT2) is one of two enzyme isoforms that catalyse the final step in the synthesis of triglycerides. IONIS-DGAT2 Rx is an antisense oligonucleotide inhibitor of DGAT2 that is under clinical investigation for the treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic … small urine output medical termWeb31 dec. 2024 · Alexander disease affects approximately 500 people in the EU. It is caused by a mutation in a protein that creates overproduction of glial fibrillary acidic protein … hik connect add shared deviceWeb29 mrt. 2024 · In addition to Alzheimer's disease, our clinical stage neurology programs include ATTR polyneuropathy, ALS, Alexander disease, Parkinson's disease and Angelman syndrome." The Phase 1b trial and its open-label long-term extension (LTE) were designed to evaluate the safety and tolerability of multiple dose levels of IONIS-MAPT Rx … hik connect apk download laptopWebIonis Pharmaceuticals, Inc.’s Post Ionis Pharmaceuticals, Inc. 39,136 followers 2y Edited Report this post ... hik connect app for amazon fire tabletWeb19 aug. 2024 · A Phase 1-3, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Intrathecally Administered ION373 in Patients With Alexander Disease Actual Study Start Date : Jun 1, 2024 Anticipated Primary Completion Date : Feb 1, 2024 Anticipated Study Completion … small urn for boiling waterWeb29 mrt. 2024 · "Ionis is pioneering potential therapies for serious neurological diseases with high unmet need. In addition to Alzheimer's disease, our clinical stage neurology programs include ATTR... hik connect app for kindleWeb20 apr. 2024 · Ionis is leading the way in treating the root causes of many neurological diseases and developing antisense medicines for common diseases like Alzheimer's and Parkinson's as well as rare diseases like amyotrophic lateral sclerosis (ALS) and Alexander disease. Ionis' marketed neurological disease medicines include SPINRAZA ®, the … small urns for cremation ashes